REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Geneone Life Science Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Geneone Life Science Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Geneone Life Science Co.,Ltd. is engaged in the research, development and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases. The company is based in Seoul, South Korea. Geneone Life Science Co.,Ltd. was incorporated in 1976 formerly known as VGX International Inc.

Headquarters
677-25 Yeoksam-Dong, Kangnam-Gu
Seoul; Seoul; Postal Code: 135-283

Contact Details: Purchase the Geneone Life Science Co.,Ltd. report to view the information.

Website: http://www.vgxi.com

Basic Information
Total Employees:
Purchase the Geneone Life Science Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Geneone Life Science Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Geneone Life Science Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Geneone Life Science Co.,Ltd. report to view the information.
Incorporation Date:
January 27, 1976
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
14.73%
Subsidiaries
Dong-Il Interlining, Ltd.
100%
Vgxi, Inc.
100%
Company Performance
Financial values in the chart are available after Geneone Life Science Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
3.81%▲
Total operating revenue
10.52%▲
Operating profit (EBIT)
19.01%▲
EBITDA
40.36%▲
Net Profit (Loss) for the Period
20.81%▲
Total assets
-24.12%▼
Total equity
-35.76%▼
Operating Profit Margin (ROS)
37.22%▲
Net Profit Margin
39.84%▲
Return on Equity (ROE)
-3.75%▼
Debt to Equity Ratio
15.71%▲
Quick Ratio
-0.41%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo